Upon its establishment in 1992, Medinol revolutionized the field of interventional cardiology with the invention of the flexible closed cell stent design. This allowed us to create the first stent with optimal support without sacrificing its flexibility. It also allowed, for the first time, to create coronary stents longer than 15mm. As a pioneer in the field of stenting solutions, Medinol has continuously advanced stenting technology by creating increasingly effective products.
Our products excel in combining the flexibility needed to facilitate safe, quick & easy deployment, with conformability to the vessel shape and the stability needed to maintain long-lasting scaffolding & clinical outcome.
Medinol’s unique core technology, robust production capabilities,
unparalleled quality control and breakthrough designs are the aggregated
result of our team’s multidisciplinary expertise.
With the introduction of a new line of stenting solutions and strategic partnerships with leading global companies, Medinol maintains its unique position as an innovation leader.
